Price $2.17 |
Market Cap
66.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
0.4
|
P/B
1.92
|
P/S
2.14
|
Dividend %
-
|
|
P/CF
2.3
|
P/FCF
3.9
|
Op. Cash Flow
3.7K
|
FCF
0.5
|
|
Op. Margin
-14.30%
|
Net Margin
-18.70%
|
ROE
-20.60%
|
ROI
29.00%
|
|
ROA
-13.40%
|
EPS Growth
85.80%
|
Current Ratio
1.4
|
Debt/Equity
35.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $21.47 | - | - | 7.55B | Strong Buy |
| Xtant Medical Holdings Inc (XTNT) | $2.98 | - | - | 45.5M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.28 | - | - | 10.6M | Strong Buy |
| ImmuCell Corporation (ICCC) | $6.64 | - | - | 44.5M | Strong Buy |
| Cocrystal Pharma Inc (COCP) | $2.21 | - | - | 74.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
